Article Information
History
- September 17, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Brechje de Gier1,*,
- Marjolein Kooijman1,
- Jeanet Kemmeren1,
- Nicolette de Keizer2,
- Dave Dongelmans3,
- Senna C.J.L. van Iersel1,
- Jan van de Kassteele1,
- Stijn P. Andeweg1,
- the RIVM COVID-19 epidemiology and surveillance team1,
- Hester E. de Melker1,
- Susan J. M. Hahné1,
- Mirjam J. Knol1 and
- Susan van den Hof1
- 1Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
- 2Amsterdam UMC, University of Amsterdam, Department of Medical Informatics, Amsterdam Public Health research institute, Amsterdam, The Netherlands; National Intensive Care Evaluation (NICE) foundation, Amsterdam, the Netherlands
- 3National Intensive Care Evaluation (NICE) foundation, Amsterdam, the Netherlands; Amsterdam UMC, location AMC, University of Amsterdam, Department of Intensive Care Medicine, Amsterdam, The Netherlands
- ↵* Corresponding author; email: brechje.de.gier{at}rivm.nl